Evidence map›Paper›PMID 26622090›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2015

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor.

Esad Alibasic, Enisa Ramic, Amila Bajraktarevic, Farid Ljuca, Olivera Batic-Mujanovic, Muharem Zildzic

Open access · greenAbstract readCase Reports
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Esad AlibasicDepartment of Family Medicine, Primary Health Care Center Kalesija, Kalesija, Bosnia and Herzegovina.
Enisa RamicDepartment of Family Medicine, Primary Health Care Center and Polyclinics Dr Mustafa Sehović Tuzla, Tuzla, Bosnia and Herzegovina.
Amila BajraktarevicDepartment of Family Medicine, Primary Health Care Center and Polyclinics Dr Mustafa Sehović Tuzla, Tuzla, Bosnia and Herzegovina.
Farid LjucaDepartment of Physiology, Faculty of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.
Olivera Batic-MujanovicDepartment of Family Medicine, Primary Health Care Center and Polyclinics Dr Mustafa Sehović Tuzla, Tuzla, Bosnia and Herzegovina.
Muharem ZildzicFaculty for health sciences, University of Zenica, Zenica, Bosnia and Herzegovina.
University Clinical Center Tuzla · BAPublic Health Institute of the Republic of Srpska · BAUniversity of Tuzla · BAUniversity of Zenica · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTimely recognition and optimal management of atherogenic dyslipidemia (AD) and residual vascular risk (RVR) in family medicine.

backgroundThe global increase of the incidence of obesity is accompanied by an increase in the incidence of many metabolic and lipoprotein disorders, in particular AD, as an typical feature of obesity, metabolic syndrome, insulin resistance and diabetes type 2. AD is an important factor in cardio metabolic risk, and is characterized by a lipoprotein profile with low levels of high-density lipoprotein (HDL), high levels of triglycerides (TG) and high levels of low-density lipoprotein (LDL) cholesterol. Standard cardiometabolic risk assessment using the Framingham risk score and standard treatment with statins is usually sufficient, but not always that effective, because it does not reduce RVR that is attributed to elevated TG and reduced HDL cholesterol. RVR is subject to reduction through lifestyle changes or by pharmacological interventions. In some studies it was concluded that dietary interventions should aim to reduce the intake of calories, simple carbohydrates and saturated fats, with the goal of reaching cardiometabolic suitability, rather than weight reduction. Other studies have found that the reduction of carbohydrates in the diet or weight loss can alleviate AD changes, while changes in intake of total or saturated fat had no significant influence. In our presented case, a lifestyle change was advised as a suitable diet with reduced intake of carbohydrates and a moderate physical activity of walking for at least 180 minutes per week, with an recommendation for daily intake of calories alignment with the total daily (24-hour) energy expenditure (24-EE), depending on the degree of physical activity, type of food and the current health condition. Such lifestyle changes together with combined medical therapy with Statins, Fibrates and Omega-3 fatty acids, resulted in significant improvement in atherogenic lipid parameters.

conclusionUnsuitable atherogenic nutrition and insufficient physical activity are the new risk factors characteristic for AD. Nutritional interventions such as diet with reduced intake of carbohydrates and calories, moderate physical activity, combined with pharmacotherapy can improve atherogenic dyslipidemic profile and lead to loss of weight. Although one gram of fat release twice more kilo calories compared to carbohydrates, carbohydrates seems to have a greater atherogenic potential, which should be explored in future.

Indexed as

AtherosclerosisDyslipidemiasHumansHypolipidemic AgentsMaleMiddle AgedPhysicians, FamilyRisk AssessmentRisk FactorsRisk Reduction BehaviorHypolipidemic Agentsatherogenic dyslipidemiafibrateslifestyle changesomega-3 fatty acidsresidual vascular riskstatins

Identifiers

PMID26622090
PMCPMC4639368
OpenAlexW1891006138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.